Journal article
Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
Abstract
Background Inflammation plays a pivotal role in coronary artery disease (CAD). The anti-inflammatory drug colchicine seems to reduce ischemic events in patients with CAD. So far there is equipoise about its safety and impact on mortality. Methods and Results To evaluate the utility of colchicine in patients with acute and chronic CAD, we performed a systematic review and meta-analysis. MEDLINE, EMBASE, Cochrane CENTRAL and conference abstracts …
Authors
Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger‐Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F
Journal
Journal of the American Heart Association, Vol. 10, No. 16,
Publisher
Wolters Kluwer
Publication Date
August 17, 2021
DOI
10.1161/jaha.121.021198
ISSN
2047-9980